eye treatment biosimilar
Scope
Date
~
-
Retail
Korean convenience stores push exports of own brand products
South Korean convenience store chains are accelerating exports of food products under their private brands as the domestic market competition is int...
Jan 30, 2024 (Gmt+09:00)
-
Automobiles
Hyundai Mobis eyes strong overseas orders again in 2024
Hyundai Mobis Co., the world’s sixth-largest automotive parts maker, known as Mobis outside of its home South Korea, expects another strong ye...
Jan 29, 2024 (Gmt+09:00)
-
Beauty & Cosmetics
Korean cosmetics makers' profits soar as niche brands grow
Kolmar Korea Co. and Cosmax Inc., South Korea’s leading cosmetics suppliers to multinational conglomerates like L'Oréal S.A., are enjoy...
Jan 18, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to export three anticancer drugs to Europe
South Korea’s Celltrion Inc. announced on Thursday that it has secured supply contracts for three anticancer biosimilars in European countries...
Jan 18, 2024 (Gmt+09:00)
-
Bio & Pharma
Kobiolabs gets Chinese patent for obesity treatment strain
South Korean microbiome-based new drug development company Kobiolabs Co. announced on Wednesday that it has a patent for its obesity treatment strai...
Jan 17, 2024 (Gmt+09:00)
-
Energy
Korean wind power companies foresee tailwind from Taiwan, US
South Korean wind power companies such as SK oceanplant Co., HD Hyundai Electric Co. and CS Wind Corp. are expected to get a tailwind from Taiwan&rs...
Jan 16, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion Holdings eyes Nasdaq IPO by early 2025: chairman
South Korean biosimilar giant Celltrion Group is planning to debut on the Nasdaq market by early 2025, founder and Chairman Seo Jung-jin said at the...
Jan 16, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to expand Yuflyma supply network in Europe
South Korea’s Celltrion Inc. announced on Friday that it will supply its biosimilar Yuflyma (active ingredient: adalimumab) for the treatment ...
Jan 12, 2024 (Gmt+09:00)
-
Korean innovators at CES 2024
LG Elec to raise capex, R&D spending; eyes acquisition
LAS VEGAS -- LG Electronics Inc., the leading global home appliance maker, plans to spend more on capital expenditures, as well as research and deve...
Jan 11, 2024 (Gmt+09:00)
-
Electronics
Samsung Electro-Mechanics eyes turnaround with Galaxy AI
Samsung Electro-Mechanics Co., the top electronic components maker in South Korea, aims for a turnaround this year with the launch of the first arti...
Jan 10, 2024 (Gmt+09:00)
-
Bio & Pharma
Kobiolabs gets US patent for oral obesity drug candidate
Kobiolabs Co., a South Korean microbiome-based new drug development company, announced on Wednesday that it has a patent for Roseburia intestinalis ...
Jan 10, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung eyes biotech investments via Flagship Pioneering
Samsung C&T Corp., Samsung Biologics Co. and Samsung Bioepis Co. will ramp up investments in US biotechnology startups in collaboration with Fla...
Jan 09, 2024 (Gmt+09:00)
-
Infrastructure
IGIS taps managing director Oh Taesuk as infrastructure head
IGIS Asset Management Co., a leading real estate firm in South Korea, said last week it has tapped Oh Taesuk, a real asset expert with more than 20 ...
Jan 08, 2024 (Gmt+09:00)
-
Bio & Pharma
Inventage Lab, Yuhan to co-work for obesity treatment
South Korea’s Inventage Lab Inc. announced on Friday that it has signed a joint development agreement with Yuhan Corp. for a long-acting inj...
Jan 05, 2024 (Gmt+09:00)
-
Korean chipmakers
Samsung eyes $8.8 billion 2024 chip profit: sources
Samsung Electronics Co. seeks to rake in 11.5 trillion won ($8.8 billion) in operating profit from its semiconductor business this year, swiveling f...
Jan 02, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Celltrion to sell portfolio of Takeda drugs to CBC Group
South Korea’s Celltrion Inc. will divest of a portfolio of Takeda Pharmaceutical's prescription medicines sold in Asia to CBC Group, a Singapo...
Jan 01, 2024 (Gmt+09:00)
-
Business & Politics
South Korea eyes new Arab boom via free trade deal with GCC nations
South Korea has struck a free trade agreement with the Gulf Cooperation Council (GCC), a group of six Arab nations, paving the way for Seoul to stre...
Dec 28, 2023 (Gmt+09:00)
-
Bio & Pharma
ViGenCell, NK/T cell lymphoma treatment ‘VT-EBV-N’ designated as orphan drug in Europe
ViGenCell, a company specializing in immune cell therapy, announced on the 19th that its NK/T cell lymphoma treatment "VT-EBV-N" has been designated...
Dec 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval of Xolair biosimilar in Canada
South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has applied for CT-P39, a biosimilar of the treatment of asth...
Dec 27, 2023 (Gmt+09:00)
-
Artificial intelligence
Naver to join race with EQT, Goldman Sachs for Korean SW firm
Naver Corp. is set to go up against global major private equity firms such as EQT Partners AB and Goldman Sachs Private Equity Group to acquire a So...
Dec 20, 2023 (Gmt+09:00)
-
Bio & Pharma
DNA testing kit maker Celemics eyes foray into US, India
Celemics Inc., a South Korean diagnostic reagent producer, is gearing up for its foray into the US and India next year in its first step toward glob...
Dec 20, 2023 (Gmt+09:00)
-
Bio & Pharma
ToolGen gets FDA approval for TGT-001 as ODD
South Korean genome editing developer ToolGen Inc. announced on Monday that its application for orphan drug designation (ODD) of the gene correction...
Dec 18, 2023 (Gmt+09:00)
-
Batteries
Hyundai-invested SES to provide Li-Metal battery B samples, eyes UAM
SES AI Corp., a high-performance battery maker backed by several global automakers such as GM and Hyundai Motor Co., has moved one step closer to co...
Dec 13, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea’s GC Cell targets global cell therapy CDMO business
GC Cell Corp., an affiliate of South Korea’s major pharmaceutical company GC Biopharma Corp., is targeting the cell therapy contract developme...
Dec 12, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Vegzelma listed on US PBM preferred drug list
South Korea's Celltrion Healthcare Co. announced on Tuesday that its anti-cancer biosimilar Vegzelma (active ingredient: bevacizumab) was listed as ...
Dec 12, 2023 (Gmt+09:00)
-
Chemical Industry
Samyang launches industrial water treatment products
South Korean chemical and food company Samyang Corp. announced on Monday that it released new industrial water treatment materials Triraite Reverse ...
Dec 11, 2023 (Gmt+09:00)
-
Robotics
Doosan Robotics eyes top spot in cobot market after Oct IPO
SUWON – South Korea’s Doosan Robotics Inc. is aiming for the top spot in the collaborative robot market excluding China, zooming in on t...
Dec 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare's Herzuma selected as funded brand in NZ
Celltrion Healthcare Co. announced on Thursday that its biosimilar anticancer drug Herzuma (active ingredient trastuzumab) for breast and gastr...
Dec 07, 2023 (Gmt+09:00)
-
Energy
KHNP eyes Canada's nuclear energy project with ARC, NB Power
Korea Hydro and Nuclear Power Co. (KHNP) said on Wednesday it has signed a non-binding agreement with ARC Clean Technology Canada Inc. and New Bruns...
Nov 29, 2023 (Gmt+09:00)
-
Artificial intelligence
Hancom to unveil document creator like Mircrosoft's Copilot
Hancom Inc., a homegrown office suite developer in South Korea, is set to speed up its artificial intelligence business with a beta service of AI-po...
Nov 28, 2023 (Gmt+09:00)